Las Vegas, NV, Jan. 26, 2016 -- EQ Labs, Inc. (“EQ.” or “the Company”) (OTC.BB: EQLB), is pleased to announce the new design and marketing of our lead product “Last Shot”.
“EQ LABS, is proud to announce its new design 8.04 oz. Cranberry flavor can, requested by a major distribution company, is being rolled out in the Las Vegas market as we speak,” states Mo Owens, CEO of EQ. “LastShot product is being made available to our customers through bars, night clubs, hotel resorts and golf courses throughout the Las Vegas area.” Mr. Owens further stated, “The design matches the product in appeal and finish. We see this quickly becoming a leader in its category.”
About EQ Lab, Inc.:
EQ Labs, Inc is a leader in the marketing and development of measured product release devices for the retail market. Its products will be sold through major retail stores, casinos, beverage distribution outlets and chains throughout the US. Leading products include 5 Cal/2 Carbs DIETARY SUPPLEMENT ENERGIZE *HYDRATE* DETOX Last Shot 3 in 1 Hangover Protection Cranberry Cold Beverage.
Safe Harbor:
This news release contains “forward-looking statements” as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. These forward-looking statements generally can be identified by phrases such as EQ Labs, Inc. or its management “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates” or other words or phrases of similar import. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new business opportunities and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report, our quarterly reports and other periodic reports filed from time-to-time with the OTC Markets.
EQ Labs, Inc Maurice Owens, President and CEO Phone: (702) 806-5943 Web: www.Drinkeq.com Email: [email protected] Twitter: eqceo


Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 



